Senegalese Customs seizes counterfeit medicines in excess of 500 million CFA Francs
The Senegalese Customs Service executed a series of search and seizure operations during mid-November, forming part of a nation-wide strategy to address the distribution and sale of counterfeit narcotics and medicines.
An estimated 400 kilograms of Indian Hemp, valued at 48 million CFA Francs, was seized in Keur Ayip, a village located on the border shared with the Gambia. In another operation, executed in Sandiara, authorities took possession of 280 kilograms of brown cannabis and 59 cartons of counterfeit medicines, weighing around 880 kilograms, were also recovered by the Foundiogne maritime brigade just off the coast of Djinack. The latter shipment included antibiotics and anti-inflammatory medication of an estimated value of 232 million CFA Francs.
The importation and distribution of counterfeit medicines has plagued West African countries for many years and not only has a negative impact on the economy, but also poses severe health risks to the public at large, in light of the fact that counterfeit products are generally substandard or simply ineffective. The recent operations executed by the Senegalese Customs Service highlight its commitment to intensify border controls and to collaborate with local law enforcement to combat against the trafficking of counterfeit goods.

OAPI - New Official Fees for Patents and Utility Models
As part of the implementation of Annex I of the revised Bangui Agreement, OAPI has published new official fees which apply to all patent and utility model applications fled after 1 January 2025. This ...
February 05 2025

Libya – Trade Mark Update
The Ministry of Economy in Libya recently issued a decree outlining updated requirements for trade mark renewals. Upon renewal, trade mark proprietors are now required to submit a financial statement ...
January 22 2025

The Fine Print in Claims-Made Policies: When a Claim Is Not a Claim
The interpretation of what constitutes a claim under a claims-made policy is often a contentious issue. Ambiguities in policy wording frequently lead to disagreements between policyholders and insurer...
January 21 2025